Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
Optimal cell type as cell-based therapies for heart failure (HF) remains unclear. We sought to compare the safety and efficacy of direct intramyocardial transplantation of human embryonic stem cell-derived car...
Source: Stem Cell Research and Therapy - Category: Stem Cells Authors: Songyan Liao, Yuelin Zhang, Sherwin Ting, Zhe Zhen, Fan Luo, Ziyi Zhu, Yu Jiang, Sijia Sun, Wing-Hon Lai, Qizhou Lian and Hung-Fat Tse Tags: Research Source Type: research
More News: Cardiology | Heart | Heart Failure | Heart Transplant | Stem Cell Therapy | Stem Cells | Transplants